Literature DB >> 17713679

Current situation of Chagas disease in Central America.

Carlos Ponce1.   

Abstract

Chagas disease in Central America is known since 1913 when the first human case was reported in El Salvador. The other Central American countries reported their first cases between 1933 and 1967. On October 1997 was launched the Central American Initiative for Chagas Disease Control (IPCA). The objectives of this sub-regional Initiative are: (1) the elimination of Rhodnius prolixus in Central America; (2) the reduction of the domiciliary infestation of Triatoma dimidiata; and (3) the elimination of the transfusion transmission of Trypanosoma cruzi. Significant advancements being close to the elimination of R. prolixus in Central America and the control of the transfusion transmission has been a transcendent achievement for the sub-region. The main challenges that the IPCA will have in the close future are: developing effective strategies for control and surveillance of T. dimidiata; and surveillance of other emerging triatominae species like R. pallescens, T. nitida, and T. ryckmani.

Entities:  

Mesh:

Year:  2007        PMID: 17713679     DOI: 10.1590/s0074-02762007005000082

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  18 in total

1.  Comparative field trial of alternative vector control strategies for non-domiciliated Triatoma dimidiata.

Authors:  Jhibran Ferral; Leysi Chavez-Nuñez; Maria Euan-Garcia; Maria Jesus Ramirez-Sierra; M Rosario Najera-Vazquez; Eric Dumonteil
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

2.  Human trypanosomiasis in the eastern region of the Panama Province: new endemic areas for Chagas disease.

Authors:  José E Calzada; Vanesa Pineda; Juan D Garisto; Franklyn Samudio; Ana Maria Santamaria; Azael Saldaña
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  Vector blood meals are an early indicator of the effectiveness of the Ecohealth approach in halting Chagas transmission in Guatemala.

Authors:  Mariele J Pellecer; Patricia L Dorn; Dulce M Bustamante; Antonieta Rodas; M Carlota Monroy
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

4.  Hypothesis testing clarifies the systematics of the main Central American Chagas disease vector, Triatoma dimidiata (Latreille, 1811), across its geographic range.

Authors:  Patricia L Dorn; Nicholas M de la Rúa; Heather Axen; Nicholas Smith; Bethany R Richards; Jirias Charabati; Julianne Suarez; Adrienne Woods; Rafaela Pessoa; Carlota Monroy; C William Kilpatrick; Lori Stevens
Journal:  Infect Genet Evol       Date:  2016-08-02       Impact factor: 3.342

5.  A highly sensitive rapid diagnostic test for Chagas disease that utilizes a recombinant Trypanosoma cruzi antigen.

Authors:  C A Barfield; R S Barney; C H Crudder; J L Wilmoth; D S Stevens; S Mora-Garcia; M J Yanovsky; B H Weigl; J Yanovsky
Journal:  IEEE Trans Biomed Eng       Date:  2011-03       Impact factor: 4.538

6.  Exploring the molecular complexity of Triatoma dimidiata sialome.

Authors:  Paula Beatriz Santiago; Carla Nunes de Araújo; Sébastien Charneau; Izabela Marques Dourado Bastos; Teresa Cristina F Assumpção; Rayner Myr Lauterjung Queiroz; Yanna Reis Praça; Thuany de Moura Cordeiro; Carlos Henrique Saraiva Garcia; Ionizete Garcia da Silva; Tainá Raiol; Flávia Nader Motta; João Victor de Araújo Oliveira; Marcelo Valle de Sousa; José Marcos C Ribeiro; Jaime Martins de Santana
Journal:  J Proteomics       Date:  2017-12-27       Impact factor: 4.044

7.  Triatoma dimidiata infestation in Chagas disease endemic regions of Guatemala: comparison of random and targeted cross-sectional surveys.

Authors:  Raymond J King; Celia Cordon-Rosales; Jonathan Cox; Clive R Davies; Uriel D Kitron
Journal:  PLoS Negl Trop Dis       Date:  2011-04-12

8.  Optimization of control strategies for non-domiciliated Triatoma dimidiata, Chagas disease vector in the Yucatán Peninsula, Mexico.

Authors:  Corentin Barbu; Eric Dumonteil; Sébastien Gourbière
Journal:  PLoS Negl Trop Dis       Date:  2009-04-14

9.  Do the new triatomine species pose new challenges or strategies for monitoring Chagas disease? An overview from 1979-2021.

Authors:  Jane Costa; Carolina Dale; Cleber Galvão; Carlos Eduardo Almeida; Jean Pierre Dujardin
Journal:  Mem Inst Oswaldo Cruz       Date:  2021-05-31       Impact factor: 2.743

10.  Recombinant Arthrobacter β-1, 3-glucanase as a potential effector molecule for paratransgenic control of Chagas disease.

Authors:  Christo Jose; Nicole Klein; Sarah Wyss; Annabeth Fieck; Ivy Hurwitz; Ravi Durvasula
Journal:  Parasit Vectors       Date:  2013-03-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.